Nivien Therapeutics
Nivien Therapeutics is developing the first small molecule drugs to enhance both chemo and immunotherapies.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Nivien Therapeutics Information
Geographic Data
Address:
City: San Francisco
State: California
Zip:
Country: United States
Financial Info
Stage:
seed
Raised Last:
$600k
Raised Total:$600k
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Nivien Therapeutics developed the first small molecule inhibitors of the Hippo signaling pathway. Read the Nivien story in The Washington Post: https://www.washingtonpost.com/national/health-science/heres-what-happened-when-i-tried-to-develop-a-new-drug-for-a-deadly-cancer/2019/01/11/
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2017 | Seed Round | 3 | $600k |
IndieBio SOSV Third Kind Venture Capital IndieBio SOSV Third Kind Venture Capital |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
